BioCrossroads
Venture Capital
Active
Indianapolis, United States
23
3M
19
1.10
2
0.17
1
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Indianapolis.
The fund is generally included in less than 2 deals every year. The typical startup value when the investment from BioCrossroads is 1-5 millions dollars. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2013.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the BioCrossroads, startups are often financed by National Institutes of Health, Elevate Ventures, Don Brown. The meaningful sponsors for the fund in investment in the same round are StepStone Angels, Spring Mill Venture Partners, Queen City Angels. In the next rounds fund is usually obtained by Triathlon Medical Venture Partners, Spring Mill Venture Partners, Prolog Ventures.
Among the most successful fund investment fields, there are Biotechnology, Diabetes. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight FlowCo, SpeechVive, Scioto Biosciences. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund raised date
- 2018-01-01
Analytics
- Total investments
- 23
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 1.10
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (16)
- Health Care (14)
- Therapeutics (4)
- Software (3)
- Pharmaceutical (3) Show 17 more
- Investments by region
-
- United States (23)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 489K
- Group Appearance index
- 0.65
- Avg. company exit year
- 3
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Allinaire Therapeutics | 27 Jan 2017 | Biotechnology, Health Care, Therapeutics | Seed | 1M | United States, Ohio, Cleveland |
| SonarMed | 16 Sep 2010 | Biotechnology, Health Care | Early Stage Venture | 1M | United States, Indianapolis, Indiana |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.